These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 10746412

  • 1. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP, Young JH, Lin TH, Yang YS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [Abstract] [Full Text] [Related]

  • 2. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P, Vieira S, Carrara P, Silva AL, Diamond J, Botelho de Sousa A, Mehta AB, Prentice HG, Guimarães JE, Hoffbrand AV, Foroni L, Parreira A.
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [Abstract] [Full Text] [Related]

  • 3. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E, Bonanad S, López JA, Martín G, Martínez J, Sanz GF, Gomis F, Pérez ML, Senent ML, Larrea L, Bolufer P, Sanz MA.
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [Abstract] [Full Text] [Related]

  • 4. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S.
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
    Chen SJ, Chen Z, Chen A, Tong JH, Dong S, Wang ZY, Waxman S, Zelent A.
    Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
    [Abstract] [Full Text] [Related]

  • 6. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D, Riccioni R, Mandelli F, Lo Coco F.
    Haematologica; 1995 Jun; 80(2):155-60. PubMed ID: 7628753
    [Abstract] [Full Text] [Related]

  • 7. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 8. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S.
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [Abstract] [Full Text] [Related]

  • 9. Absence of detectable PML-RAR alpha fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia.
    Román J, Martín C, Torres A, Jiménez MA, Andrés P, Flores R, de la Torre MJ, Sánchez J, Serrano J, Falcón M.
    Bone Marrow Transplant; 1997 Apr; 19(7):679-83. PubMed ID: 9156244
    [Abstract] [Full Text] [Related]

  • 10. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [Abstract] [Full Text] [Related]

  • 11. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 12. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
    Lin J, Han LX, Qian J, Wang YL, Qian Z, Yang XF, Sheng XJ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
    [Abstract] [Full Text] [Related]

  • 13. [Expression of PML-RAR alpha fusion transcripts detection by using RQ-PCR].
    Han LX, Lin J, Qian J, Wang YL, Qian Z, Yang XF, Sheng XJ, Yao DM.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):753-6. PubMed ID: 19176013
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
    Lazo G, Kantarjian H, Estey E, Thomas D, O'Brien S, Cortes J.
    Cancer; 2003 May 01; 97(9):2218-24. PubMed ID: 12712474
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E.
    Leukemia; 1996 Jan 01; 10(1):61-6. PubMed ID: 8558940
    [Abstract] [Full Text] [Related]

  • 20. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G, Barragán E, Bolufer P, Chillón C, García-Sanz R, Gómez T, Brunet S, González M, Sanz MA.
    Haematologica; 2000 Jul 01; 85(7):699-703. PubMed ID: 10897121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.